Health and Consumers Commission view on the implementation of Regulation (EC) No 1107/2009 ECPA/ECCA Brussels Regulatory Conference 12-13 March 2014, Brussels, Belgium Wolfgang Reinert European Commission Health and Consumers Directorate-General Unit Chemicals, contaminants, pesticides
12
Embed
Health and Consumers Health and Consumers Commission view on the implementation of Regulation (EC) No 1107/2009 ECPA/ECCA Brussels Regulatory Conference.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Health andConsumers
Health andConsumers
Commission view on the implementation of
Regulation (EC) No 1107/2009
ECPA/ECCA Brussels Regulatory Conference12-13 March 2014, Brussels, Belgium
Wolfgang Reinert
European Commission
Health and Consumers Directorate-General
Unit Chemicals, contaminants, pesticides
Health andConsumers
Health andConsumers
• New Active substances (Reg. 188/2011)- about finished- 3 substances still in the peer-review
• New Active substances (Reg. 1107/2009)- No major problems flagged- Progress made in the integration of CLP-process into review
Active substances
first approval
Health andConsumers
Health andConsumers
• List according to article 80 (7) under finalisation
• Covering a.s. approved until Jan 2013
• Regulatory framework under consultation
• Apply comparative assessment as from 1 January 2015
• List to be completed by that date
• GD comparative assessment on agenda of SCFCAH in March
Implementing measures
Candidates for Substitution
Health andConsumers
Health andConsumers
• New data requirements published in April 2013
• Apply to all a.s. and PPP dossiers as from 1 January 2016
• Transitional measures create problems for:- PPP dossier submissions after 1 January 2016, containing- a.s. of AIR2, or- new a.s. submitted before 31 December 2013- because of non-peer-reviewed information in the a.s. dossier
Implementing measures
New data requirements (DR)
Health andConsumers
Health andConsumers
• Possible solution:
• old DR exceptionally continue to apply
• to a.s. dossiers in PPP submissions
• containing a.s. to which the old DR still apply (new a.s., AIR2)
• No problems with applying new data requirements for PPP dossier in all cases as foreseen
• Amended GD and draft Reg. to be presented to SCFCAH in March
Implementing measures
New data requirements (DR)
Health andConsumers
Health andConsumers
• Relates to points 3.6.3 – 3.6.5 and 3.8.2 of Annex II to Reg. 1107/2009:- Carc. and reprotox cat. 1A and 1B- Endocrine disruption
• Element of exposure for hazard-oriented criteria
• Non-dietary exposure: legislation leaves margin of interpretation
• Guidance document under preparation:- Discussion ongoing between COM, MS and EFSA- stakeholder consultation foreseen
Interpretation issues
Negligible exposure
Health andConsumers
Health andConsumers
•
Implementing measures
Endocrine Disruptors
Health andConsumers
Health andConsumers
• Recent analyses from industry and MS on the functioning
• System is not yet working according to desire
• Yet, no thorough analysis: figures presented too divergent
• Complexity of the zonal vs. national authorisation:- Failure to comply with deadlines- Resource problems- Lack of streamlining in the procedure
• COM dedicated to the principle of mutual recognition and keen to enhance the functioning
Implementing measures
Zonal System
Health andConsumers
Health andConsumers
• Module authorisation/ mutual recognition under development
• Recently updated:- Product management- Follow-up of application process- e-mail notifications- User management- User interface
Implementing measures
Authorisation Database
Health andConsumers
Health andConsumers
• Second user acceptance testing before summer 2014
• Publication planned second semester 2014
• What next?- Expand existing EPPO codes- Implement other modules (amendment of authorisation, minor uses…)- Incorporate existing entries from MS databases- Publish catalogue of EU authorisations